How many FDA warning letters has SABA ILAC SANAYIVE received?

Argus HQ has not recorded an FDA warning letter for SABA ILAC SANAYIVE in our current dataset.

What FDA recalls has SABA ILAC SANAYIVE issued?

Argus HQ has not recorded an FDA recall tied to SABA ILAC SANAYIVE in our current dataset.

Is SABA ILAC SANAYIVE FDA compliant?

Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 0 recalls, and 1 approval record for SABA ILAC SANAYIVE. Review the linked FDA source records directly before drawing a compliance conclusion.

.hq

company

SABA ILAC SANAYIVE

Name: FDA Enforcement Actions Against SABA ILAC SANAYIVE
Creator: Argus HQ
License: https://argushq.ai/methodology

Jurisdiction: US

FDA Warning Letter timeline

V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.

fda_approval · anda2026-07-01
SABA ILAC SANAYIVE — ANDA approval: BRIMONIDINE TARTRATE AND TIMOLOL MALEATE (unspecified)

Frequently asked questions

How many FDA warning letters has SABA ILAC SANAYIVE received?: Argus HQ has not recorded an FDA warning letter for SABA ILAC SANAYIVE in our current dataset.
What FDA recalls has SABA ILAC SANAYIVE issued?: Argus HQ has not recorded an FDA recall tied to SABA ILAC SANAYIVE in our current dataset.
Is SABA ILAC SANAYIVE FDA compliant?: Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 0 recalls, and 1 approval record for SABA ILAC SANAYIVE. Review the linked FDA source records directly before drawing a compliance conclusion.

Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.